Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia in patients at risk. ## Adult Dosing * **Oral:** * **Treatment of hypokalemia:** Typically 20-60 mEq per day in divided doses. Severe hypokalemia may require higher doses, up to 100-200 mEq per day, given orally in divided doses. Maximum single oral dose is generally 25 mEq. * **Prevention of hypokalemia:** Typically 10-40 mEq per day. * **Intravenous (IV):** Dosing is highly individualized based on serum potassium levels and clinical status. Dosing must be guided by local protocol, serum potassium concentration, and ECG findings. * **Mild hypokalemia (3.0-3.4 mEq/L):** 10-20 mEq IV infused over 1-2 hours. * **Moderate hypokalemia (2.5-2.9 mEq/L):** 20-40 mEq IV infused over 2-4 hours. * **Severe hypokalemia (<2.5 mEq/L):** May require 40-80 mEq IV, potentially infused more rapidly and with cardiac monitoring. * **Maximum IV infusion rate:** Generally not to exceed 10-20 mEq per hour in patients without ECG changes and adequate urine output. Faster rates (e.g., 40 mEq/hour) may be used in life-threatening hypokalemia with continuous ECG monitoring and central venous access. * **Maximum IV concentration:** Typically limited to 40 mEq/L in peripheral lines and 60-80 mEq/L in central lines to prevent phlebitis. ## Pediatric Dosing Dosing is based on age, weight, and serum potassium levels. Specific protocols should be followed. * **Oral:** Doses range from 1-5 mEq/kg/day divided into doses. Maximum single dose not to exceed 10-20 mEq. * **Intravenous (IV):** Doses typically range from 0.5-1 mEq/kg per dose, infused slowly. Maximum daily dose is generally 3 mEq/kg/day or 200 mEq/day, whichever is less. Maximum infusion rate generally 0.5-1 mEq/kg/hour. Higher doses and rates may be used in critical situations under strict monitoring. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Reduced doses or avoidance may be necessary. Monitor potassium levels closely. * **Hepatic Impairment:** No specific dose adjustment, but monitor electrolyte balance. ## Contraindications * Hyperkalemia. * Conditions that predispose to hyperkalemia such as: severe renal impairment, untreated Addison's disease, acute dehydration, extensive tissue breakdown (e.g., severe burns, crushing injuries), certain types of muscular dystrophy. * Hypersensitivity to potassium chloride. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain (oral). * **Serious:** * **Hyperkalemia:** The most significant risk, especially with rapid IV infusion, in renal impairment, or with concomitant use of potassium-sparing agents. Symptoms include muscle weakness, paralysis, cardiac arrhythmias (including asystole), hypotension, bradycardia. * **Gastrointestinal ulceration/bleeding/perforation:** More common with sustained-release oral formulations or if taken without sufficient fluid. * **Phlebitis/vein irritation:** With IV administration. * **Arrhythmias:** Can occur with both hyperkalemia and rapid IV infusion. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors, Angiotensin II Receptor Blockers (ARBs), Aldosterone Antagonists:** Increased risk of hyperkalemia. * **NSAIDs:** May reduce potassium excretion, increasing risk of hyperkalemia. * **Heparin:** May increase risk of hyperkalemia by inhibiting aldosterone production. * **Digoxin:** Hyperkalemia can increase the risk of digoxin toxicity; hypokalemia can increase the risk of digoxin toxicity. ## Monitoring * Serum potassium levels (frequently during treatment, especially with IV administration and in patients with renal impairment). * ECG monitoring for signs of hyperkalemia (peaked T waves, widened QRS complex, loss of P waves) and hypokalemia (flattened T waves, U waves, ST depression). * Renal function (BUN, creatinine). * Fluid and electrolyte balance. * Signs and symptoms of hyperkalemia and GI distress. ## Clinical Pearls * Always dilute IV potassium chloride in an IV fluid bag before administration. Never give as a bolus. * Oral potassium chloride should be taken with meals and a full glass of water to minimize GI upset and reduce the risk of esophageal irritation or ulceration. * Rapid IV infusion of potassium chloride is associated with significant risks, including cardiac arrest, and should only be performed in monitored settings with appropriate equipment readily available. * Elective correction of hypokalemia is generally preferred over urgent correction when possible. * Consider the underlying cause of hypokalemia; simply replacing potassium may not be sufficient if the cause is not addressed (e.g., diuretic use, vomiting, diarrhea, magnesium deficiency). *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for clinical judgment. Always refer to the most current prescribing information and institutional protocols for complete and up-to-date guidance.